glp 1 drugs novo nordisk GLP-1 RA education Novo's patent expires in India:
Description
Some patients may need extra support for the continuance of healthy lifestyle behaviors, even with long-term use of pharmacologic agents
Allulose consumed with carbohydrate-containing meals may interact with glucose-sensing mechanisms in enteroendocrine cells, potentially enhancing or modifying the incretin response
Dapagliflozin monotherapy in drug-nave patients with diabetes: A randomized-controlled trial of low-dose range
Conclusions GLP-1 RAs are effective and safe for treating SICR and WGR after bariatric surgery
The patients studied by Chen et al
